Iridium(iii) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity

Abstract

Novel Ir(iii)–naproxen (NPX) conjugates exhibit synergistic biological activity through anti-inflammatory, anti-metastasis, induction of apoptosis and immunotherapy.